wow! This is about as outrageous as any company can get. They sold 129 MM of drugs, 30 MM goes to CEO comp in ONE QTR, 38 MM goes to R&D, makes 18 MM profits. LOL. I hope shareholders of this company really think Martin[e] is really worth that much. 30 MM in one qtr. It was 14 MM last qtr.
Worthy of a share-holders' derivative suit. Sounds like executives looting the treasury, with the blessings of the directors. New regulations may even trigger FBI interest. Let them explain why the sticky fingers to a judge on their way to the pokie.